A real world study analysing efficacy and safety of gemtuzumab in combination with chemotherapy FLAG+/-Ida and azacitidine in acute myeloid leukemia
Latest Information Update: 03 Aug 2021
At a glance
- Drugs Gemtuzumab ozogamicin (Primary) ; Cytarabine; Fludarabine; Granulocyte colony-stimulating factors; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 03 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association